diphenyl has been researched along with alpha-synuclein in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arndt-Jovin, DJ; Becker, D; Giese, A; Griesinger, C; Lázaro, DF; Leonov, A; Outeiro, TF; Ryazanov, S; Schön, M; Schön, MP; Turriani, E | 1 |
| Gadhavi, J; Gupta, S; Hivare, P; Hoda, N; Maqbool, M | 1 |
2 other study(ies) available for diphenyl and alpha-synuclein
| Article | Year |
|---|---|
Treatment with diphenyl-pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death.
Topics: alpha-Synuclein; Animals; Autophagy; Benzodioxoles; Biphenyl Compounds; Cell Death; Cell Line, Tumor; Dopaminergic Neurons; Female; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Melanoma; Mice; Mice, Nude; Parkinson Disease; Pyrazoles; Ubiquitin-Protein Ligases | 2017 |
Diphenyl triazine hybrids inhibit α-synuclein fibrillogenesis: Design, synthesis and in vitro efficacy studies.
Topics: alpha-Synuclein; Amyloid; Biphenyl Compounds; Drug Design; Humans; Models, Molecular; Parkinson Disease; Protein Aggregates; Protein Aggregation, Pathological; Triazines | 2020 |